
|Articles|December 10, 2015
Special Section Media, Communications & Social Media
Author(s)DIA
Advertisement
From enhancing the clinical trial recruitment process to providing a powerful tool for communicating drug safety, mobile technology and social media are quickly becoming part of the biopharmaceutical landscape. This Special Section of the December 2015 Global Forum explores the intersection of digital technology with the patient experience, and showcases forward-thinking applications of technology into the drug development process.
To read this article,
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5




